Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos

Inward Investment
Return to: PBR Home | Inward Investment | News
Search Refinements

Inward Investment News

View news from other Pharmaceutical sectors:
121-135 of 421 results
Valeant to purchase certain assets from Atlantis
By PBR Staff Writer
Valeant Pharmaceuticals has signed an agreement to obtain certain assets from Atlantis Pharma, including products in the gastro, analgesics and anti-inflammatory therapeutic categories, for approximately $71m.
Inward Investment > News
Mylan to expand operations in Ireland
By PBR Staff Writer
Mylan, a generic pharmaceutical manufacturer, will spend $100m in Ireland over the next five years to expand its operations in the cities of Dublin and Galway.
Inward Investment > News
Valeant takes over Pedinol Pharmacal
By PBR Staff Writer
Valeant Pharmaceuticals has purchased Pedinol Pharmacal and the transaction is expected to be immediately accretive.
Inward Investment > News
Takeda America to take over URL Pharma
By PBR Staff Writer
Takeda America Holdings has entered into an agreement to purchase URL Pharma for an upfront payment of $800m and future performance-based contingent earn out payments.
Inward Investment > News
Biocon invests in new integrated research and development centre
By PBR Staff Writer
Biocon has invested in new integrated research and development centre, Biocon Research Center (BRC), in South-East Asia to conduct research on biologics that will deal with unmet medical needs.
Inward Investment > News
OPKO Health takes over ALS Distribuidora
By PBR Staff Writer
OPKO Health, a multi-national biopharmaceutical and diagnostics company, has purchased ALS Distribuidora.
Inward Investment > News
OWH signs patent agreement with Eisai for pro-drug technology
By PBR Staff Writer
OneWorld Health (OWH) has entered into a nonexclusive patent agreement with Eisai for a water-soluble pro-drug technology patent.
Inward Investment > News
Bausch + Lomb to purchase ISTA
By PBR Staff Writer
Bausch + Lomb has signed a definitive agreement to acquire ISTA Pharmaceuticals for $9.10 per share in cash, or a total of approximately $500m.
Inward Investment > News
Sanofi to purchase Pluromed
By PBR Staff Writer
Sanofi has entered into an agreement to acquire Pluromed, a medical device company based in Woburn, Massachusetts, US.
Inward Investment > News
CareFusion signs deal to acquire Phacts
By PBR Staff Writer
CareFusion has signed an agreement to acquire Phacts, a Seattle-based technology and consulting company that helps hospital pharmacies better manage inventory, reduce pharmaceutical costs and streamline operations.
Inward Investment > News
Islet Sciences to take over DiaKine Therapeutics
By PBR Staff Writer
Islet Sciences has entered into a share exchange agreement to acquire DiaKine Therapeutics (DTI), a development stage company commercializing novel immune modulators for the treatment of diabetes and related complications.
Inward Investment > News
Dompé to acquire Italian ophthalmology company
By PBR Staff Writer
Italy's biopharmaceutical company, Dompé has signed a definitive agreement to acquire remaining 51% stake in Anabasis, a privately held Italian research and development biopharmaceutical company.
Inward Investment > News
Catalent takes over Aptuit clinical trial supplies business
By PBR Staff Writer
Catalent Pharma Solutions has completed the acquisition of the clinical trial supplies business of Aptuit.
Inward Investment > News
Valeant to purchase Eyetech
By PBR Staff Writer
Valeant Pharmaceuticals has entered into an agreement to acquire Eyetech, a privately-owned ophthalmic biotechnology company.
Inward Investment > News
Bristol-Myers Squibb takes over Inhibitex
By PBR Staff Writer
Bristol-Myers Squibb Company has completed its acquisition of Inhibitex, a drug development company, at a purchase price of $26 per share.
Inward Investment > News
121-135 of 421 results